PubMed Health⌕ Search

Biomedical subjects

L Baron

Publications and source records attributed to L Baron.

24 records · Page 2Linked to original sources

Rape and its relation to social disorganization, pornography and inequality in the USA.

A theoretical model seeks to integrate social disorganization and feminist theories of rape, reporting an empirical test of that model using data on rapes per 100,000 population known to the police in the 50 states of the United States. The model includes the following aspects of the social organization of the states: social disorganization (measured by a six item index), sexual inequality (measured by a status of women index to men), pornography (measured by a sex magazine circulation index for eight sexually explicit magazines) and the level of culturally legitimate violence (measured by a 12 item legitimate violence index using indicators like corporal punishment in schools. There were marked differences between states of the USA in the incidence of rape during the 1980-82. Path analysis was used to test the theoretical model, which posits rape as a function of the direct and indirect effects of social disorganization, sexual inequality, pornography, legitimate violence and seven control variables. The results show that all four variables play an important part in explaining differences between states in rape; and that together, the variables in the model explain 83 per cent of the state-to-state variation in rape. Women are in much greater danger of being raped in some American states than in others. Since the FBI began compiling statistics on rape, states like Alaska, Nevada, and California have consistently registered many more rapes per capita than North Dakota, Maine, and Iowa. What factors account for such differences between states? Could the variation in the rape rate be explained by four aspects of the social structure of states: (1) the proliferation of pornography (2) sexual inequality (3) culturally legitimate violence and (4) social disorganization. Each factor represents a theory which will be examined within the context of an integrated theory on rape.

Erotica↗

Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient.

Clotting factor activities and coagulation screening tests in 36 massively transfused patients were measured after every 12 units of blood and whenever diffuse microvascular bleeding (MVB) developed. Moderate deficiencies in clotting factors were common, but they were not associated with MVB. MVB was associated with severe abnormalities of coagulation, i.e. a fibrinogen level less than 0.5 g/l or clotting factor levels less than 20%. The quantitative relationship between the prothrombin (PT) and partial thromboplastin (PTT) times and underlying clotting factor levels was explored by multiple linear regression. Clotting factor levels accounted for only 65-85% of the variability in these tests. However, clotting factor activities less than 20% were reliably reflected by marked prolongations of the PT and PTT (values greater than 1.8 times control). Our data suggest that commonly used replacement formulas are not likely to prevent MVB, since consumption of platelets and/or clotting factors, rather than simple dilution, is a major cause of the deficiencies leading to MVB. Modified whole blood alone was sufficient replacement therapy for most patients. Guidelines for transfusion of supplemental components during massive transfusion are given.

Blood Coagulation Factors↗

Prophylactic platelet administration during massive transfusion. A prospective, randomized, double-blind clinical study.

Prior studies at Harborview Medical Center have suggested that dilutional thrombocytopenia is a major etiology of microvascular, nonmechanical bleeding (MVB). We undertook a prospective randomized double-blind clinical study to compare the prophylactic effects of 6 units of platelet concentrates (PLT) versus 2 units of fresh frozen plasma (FFP) administered with every 12 units of modified whole blood in patients undergoing massive transfusion (12 or more units in 12 hours). After exclusions, three of 17 patients who received PLT and three of 16 patients who received FFP developed MVB, an incidence no different from our previous findings. Regression lines of platelet counts during transfusion were no different between groups, and both groups had higher platelet counts than predicted from a standard washout equation. Only one patient had evidence of dilutional thrombocytopenia as a cause for MVB. Prophylactic platelet administration is not warranted as a routine measure to prevent MVB.

Adult↗